Pharmacokinetic tuning of protein–antigen fusions enhances the immunogenicity of T-cell vaccines
© 2020, The Author(s), under exclusive licence to Springer Nature Limited. The formulations of peptide-based antitumour vaccines being tested in clinical studies are generally associated with weak potency. Here, we show that pharmacokinetically tuning the responses of peptide vaccines by fusing the...
Main Authors: | , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC
2021
|
Online Access: | https://hdl.handle.net/1721.1/135964 |